血清炎症因素作为心力衰竭严重程度和预后的预测因素:一个队列研究
Zijun Jiang1,2, Lwembawo Joseph1, Nan Niu1
1Cardiology Department, First Department of Cardiology, The Second Affiliated Hospital of Dalian Medical University, Dalian, P.R. China.
Medicine
|March 6, 2026
概括
血清炎症标志物,如白素2受体,白素6和白素1β,与心力衰竭的严重程度和预后有关. 较高的水平预示着更糟糕的结果,并在一年内增加不良心血管事件.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 生物标志物 生物标志物
背景情况:
- 慢性心力衰竭 (HF) 的进展与炎症有关.
- 在HF中,特定的血清炎症生物标志物的预后意义需要进一步调查.
研究的目的:
- 为了检查血清炎症因子和住院慢性HF患者的疾病严重程度之间的关系.
- 评估这些因素与慢性HF1年预后之间的关联.
主要方法:
- 在524名住院HF患者中分析了临床数据,心脏功能等级和血清炎症因子.
- 使用后勤回归用于风险因素分析和Kaplan-Meier/COX回归用于1年后续期的预后评估.
主要成果:
- 介质素2受体 (IL-2R),介质素6 (IL-6) 和介质素1β (IL-1β) 水平与HF严重程度相关 (纽约心脏协会等级).
- 升高的IL-2R和IL-6水平与在一年内发生重大心血管不良事件的更高发病率有关.
- 高IL-1β,IL-2R和IL-6水平,以及低瘤亡因子α,独立预测慢性HF患者的不良结果.
结论:
- 介质素2受体,介质素6和介质素1β是慢性心力衰竭的严重程度和预后的重要预测因素.
- 这些炎症生物标志物可能有助于风险分层和慢性HF患者的管理.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
670
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
670
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
842
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
842
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.0K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Heart Failure IV: Classification and Diagnostic Evaluation
505
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
505
Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Heart Failure III: Clinical Manifestations
749
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
749

